Symptoms and Outcomes of COVID-19 in Elderly Recipients of Influenza and COVID-19 Vaccines

Health providers and policymakers aim to prevent or reduce the severity of disease outcomes globally.

The present study aimed to explore the outcomes and common symptoms of COVID-19 in the elderly population vaccinated against influenza and COVID-19 in hospitals of Ramsar and Tonekabon cities in Iran.

To participate in the present cross-sectional descriptive study, 11 qualified subjects were selected through a census. The data collection instruments included the “Demographic and clinical questionnaire” and “Registration form of sampled patients with acute disease syndrome”. The data were analyzed in SPSS 24 using descriptive statistics (frequency).

The average age of the participants was 70.63±5.85 years. As the results showed, mild cardiovascular symptoms were found in 6 participants (54.5%), lower respiratory system symptoms in 5 (45.5%), nervous system symptoms in 4 (36.4%), and auxiliary symptoms in 4 (36.4%). No cardiac, renal, blood or central nervous system outcomes were observed in the elderly, and the mortality rate was 0%. The findings also showed a reduction in clinical symptoms and severity of outcomes, an improvement in clinical findings, and no mortality among the elderly.

The present findings supported measures aimed at increasing the coverage of influenza and COVID-19 vaccination in people, especially the elderly.